Medicine
Economy
[Big read] Is Singapore the ultimate ‘China+1’ biopharma hub?
China’s biotech industry is becoming a formidable force in drug R&D and manufacturing. For Singapore, its rise brings new competition — but also an opportunity to strengthen its role as a trusted China+1 hub for global pharma. Lianhe Zaobao senior business correspondent Lewis Ong Yong Huat speaks with industry players and government officials to find out more.
Lewis Ong Yong Huat
09 Sep 2026
Economy
Why China’s biotech rise is harder to contain than AI
China is emerging as a biotech powerhouse, but its rise is entwined with US drugmakers through research, licensing and supply chains, making decoupling far more difficult than in AI. Academic Chen Xiangming and biopharma industry practitioner Leon Tang analyse the situation.
Chen Xiangming, Leon Tang
05 Aug 2026
Society
[Video] Effortlessly beautiful: China’s new obsession with ‘invisible’ cosmetic procedures
Why are millions of Chinese paying for cosmetic procedures that nobody is supposed to notice? The pursuit of “natural beauty” is reshaping the country’s booming medical aesthetics industry. ThinkChina’s Yi Jina finds out more.
Yi Jina
31 Jul 2026
Technology
US’s biotech scrutiny tests China’s drugmakers abroad
A proposed US bill to tighten scrutiny of biotech investment in China is casting a shadow over cross-border drug licensing, threatening a fast-growing partnership model that has fuelled innovation and global drug development.
Caixin Global
10 Jul 2026
Economy
China’s bid for a slice of the medical tourism market
Driven by vast surgical experience and lower costs, China’s medical tourism sector is expanding. However, Lianhe Zaobao correspondent Yush Chau finds out that building an international reputation and managing domestic resources remain key challenges.
Yush Chau
02 Jun 2026
Society
[Big read] China’s ‘fur kids’ fuel a billion-dollar pet boom
China’s growing love for pets has created a billion-dollar industry, with smart devices, AI services and full life-cycle care. Local governments are also backing the trend to boost domestic consumption. Lianhe Zaobao journalist Zeng Shi speaks to industry players to find out more about the shift in social attitudes and policies that have led to this growth.
Zeng Shi
30 Mar 2026
Society
Tu Zhiliang: The man who believes Chinese medicine can save the world
Just as Chinese restaurants thrive wherever there is an ethnic Chinese community, Gu Sheng Tang TCM CEO Tu Zhiliang wants the same for TCM services. Lianhe Zaobao senior lifestyle correspondent Dennis Ng speaks to the wuxia fan with a vision of saving the world through traditional Chinese medicine.
Dennis Ng
11 Mar 2026
Technology
Innovative drugs: The new battleground in US-China rivalry
The race for innovative drugs has become a defining front in US-China competition. While the US leads in original innovation, China is rapidly advancing through strategy, scale and efficiency, shaping the future of global pharmaceutical development, says NUS Emeritus Professor Ong Choon Nam.
Ong Choon Nam
09 Dec 2025
Technology
Where China stands in the nuclear medicine gold rush
China is racing to turn its vast state-backed investment and swelling domestic isotope supply into a global power in nuclear medicine — but its bold drive to lead the next wave of cancer diagnostics and therapies still faces deep structural bottlenecks.
Caixin Global
28 Nov 2025
Society
[Big read] Is assisted living — even overseas — the smart retirement move?
As Singapore’s population ages, the “silver economy” is booming. From luxury eldercare and AI companions to affordable overseas options, seniors are planning ahead. Lianhe Zaobao’s Vicki Loh speaks to providers and users shaping the future of retirement.
Vicki Loh
06 Oct 2025